Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer

BACKGROUND: To evaluate the anticancer efficacy of the combination of epigenetic modifiers and cisplatin in human ovarian cancer. METHODS: The effect of trichostatin A (TSA) and 5-aza-2′-deoxycytidine alone or in combination with low-dose cisplatin was evaluated on human ovarian cancer cell lines in...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, F, Sun, G, Zhong, M, Yu, Y, Brewer, M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593556/
https://www.ncbi.nlm.nih.gov/pubmed/23370212
http://dx.doi.org/10.1038/bjc.2013.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593556/
https://www.ncbi.nlm.nih.gov/pubmed/23370212
http://dx.doi.org/10.1038/bjc.2013.10

Ejemplares similares